000			02062 a2200553 4500
005			20250515063908.0
264		0	_c20070612
008			200706s 0 0 eng d
022			_a1535-7163
024	7		_a10.1158/1535-7163.MCT-05-0414 _2doi
040			_aNLM _beng _cNLM
100	1		_aRay, Subrata
245	0	0	_aS-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. _h[electronic resource]
260			_bMolecular cancer therapeutics _cApr 2007
300			_a1368-78 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols
650	0	4	_aAphidicolin _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aCell Cycle Proteins _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aCheckpoint Kinase 2
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aProtein Kinases _xmetabolism
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xmetabolism
650	0	4	_aS Phase _xdrug effects
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand _xadministration & dosage
650	0	4	_aTransplantation, Heterologous
650	0	4	_aTumor Suppressor Proteins _xmetabolism
700	1		_aShyam, Sunitha
700	1		_aFraizer, Gail C
700	1		_aAlmasan, Alexandru
773	0		_tMolecular cancer therapeutics _gvol. 6 _gno. 4 _gp. 1368-78
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-05-0414 _zAvailable from publisher's website
999			_c16981793 _d16981793